Avadel Pharmaceuticals (AVDL) Acquisitions: 2012-2016
Historic Acquisitions for Avadel Pharmaceuticals (AVDL) over the last 2 years, with Sep 2016 value amounting to $467,000.
- Avadel Pharmaceuticals' Acquisitions was N/A to $467,000 in Q3 2016 from the same period last year, while for Sep 2016 it was -$9.4 billion, marking a year-over-year change of. This contributed to the annual value of $628,000 for FY2016, which is N/A change from last year.
- Latest data reveals that Avadel Pharmaceuticals reported Acquisitions of $467,000 as of Q3 2016, which was up 190.06% from $161,000 recorded in Q1 2016.
- Avadel Pharmaceuticals' 5-year Acquisitions high stood at $1.4 million for Q4 2014, and its period low was -$9.4 billion during Q2 2015.
- In the last 3 years, Avadel Pharmaceuticals' Acquisitions had a median value of -$100,000 in 2014 and averaged -$1.7 billion.
- Over the last 5 years, Avadel Pharmaceuticals' Acquisitions had its largest YoY gain of 267,622.73% in 2013, and its largest YoY loss of 228,667.12% in 2013.
- Over the past 5 years, Avadel Pharmaceuticals' Acquisitions (Quarterly) stood at -$66 in 2012, then skyrocketed by 267,622.73% to $176,565 in 2013, then spiked by 667.99% to $1.4 million in 2014, then tumbled by 1,435.02% to -$9.4 billion in 2015, then reached $467,000 in 2016.
- Its Acquisitions stands at $467,000 for Q3 2016, versus $161,000 for Q1 2016 and -$9.4 billion for Q2 2015.